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Presenilin-1 deficiency leads to loss of Cajal–Retzius neurons
and cortical dysplasia similar to human type 2 lissencephaly 
Dieter Hartmann*, Bart De Strooper† and Paul Saftig‡
Background: Presenilin-1 (PS1) is a transmembrane protein that is located in
the endoplasmic reticulum and the cis Golgi apparatus. Missense mutations of
PS1 that modify γ-secretase function, leading to a pathologic processing of
amyloid precursor protein, are an important cause of familial Alzheimer’s
disease. Physiologically, the presenilins are involved in the Notch and
Wnt–β-catenin signaling pathways.
Results: PS1-deficient mice develop a cortical dysplasia resembling human
type 2 lissencephaly, with leptomeningeal fibrosis and migration of cortical-plate
neurons beyond their normal position into the marginal zone and subarachnoid
space. This disorder of neuronal migration is associated with the disappearance
of the majority of the cells of the marginal zone, notably most of the
Cajal–Retzius pioneer neurons, between embryonic days E14 and E18, and is
preceded and accompanied by disorganization of Notch-1 immunoreactivity on
the neuronal cell membranes. The marginal zone also becomes depleted of the
extracellular matrix protein reelin and chondroitin sulfate proteoglycans. At that
stage PS1 is transiently expressed in leptomeningeal fibroblasts, which are
mandatory for the trophic support of Cajal–Retzius neurons.
Conclusions: In agreement with models in which neuronal migration disorders
have been linked to a defect in Cajal–Retzius cells, the loss of most of these
cells in PS1-deficient mice leads to cortical dysplasia. Because PS1 is normally
expressed in the leptomeninges, and these become fibrotic in the PS1-
knockout mice, we favor the hypothesis that the loss of Cajal–Retzius cells is
caused by a defective trophic interaction with leptomeningeal cells, possibly
involving disruption of Notch signaling.
Background
PS1 is a multipass transmembrane protein located in the
endoplasmic reticulum and the Golgi apparatus [1–3]. It is
expressed in a variety of tissues including liver, lung,
kidney, heart and skeletal muscle [4]. Within the postnatal
brain, PS1 has been localized mostly to neurons, where it
is present mainly in the somata and dendritic trees [1,5–7].
It has also been detected by western blot analysis in pre-
natal rodent brain tissue, but its cellular distribution at this
stage is only incompletely established [8].
Missense mutations of the human PS1 gene are a major
cause of familial Alzheimer’s disease [4], leading to an
increased production of the long, strongly amyloidogenic
form of the β-A4 amyloid peptide from the amyloid pre-
cursor protein (APP) [9–12]. Deficiency of PS1 causes a
marked reduction in all forms of the β-A4 amyloid pep-
tides in neurons and an accumulation of carboxy-terminal
fragments of APP generated by α-secretase and β-secre-
tase. This indicates that PS1 deficiency leads to selective
inhibition of APP cleavage by γ-secretase, which normally
generates the carboxy terminus of the β-A4-peptide [13].
The control of protein processing by PS1 is apparently not
restricted to APP. Whereas APP deficiency causes only
mild symptoms [14], PS1-knockout mice independently
generated by several groups [13,15,16] exhibit severely
abnormal development of various tissues, resulting in late
intra-uterine or perinatal death of homozygous offspring.
The abnormal patterning of the axial skeleton and the
generalized hypotrophy of the caudal body regions in
these animals has been attributed to reduced expression
of notch-1 and dll-1 mRNA within the presomitic meso-
derm [16]. Genetic studies in Caenorhabditis elegans have
already indicated a modulatory role for presenilins in the
Notch signaling pathway [17].
The main functions of Notch are determination of cell
survival and selection of cell fate during development.
Activation of Notch leads to the proteolytic release of its
intracellular domain, which is transported to the nucleus
where it controls gene transcription [18,19]. PS1 defi-
ciency interferes with the intramembrane cleavage of
Notch [20,21] and APP [13], thus explaining at the molec-
ular level why PS1 deficiency results in deficient Notch
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signaling [16]. It has been proposed that PS1 itself has cat-
alytic activity [22].
In PS1-deficient mice, vascular lesions within the central
nervous system cause severe hemorrhage into the
parenchyma and lateral ventricles [15]. In addition, a col-
lapse of the ventricular proliferative zone in embryos during
late pregnancy has been described; this could either repre-
sent a secondary effect of the hemorrhages or be the result
of a disruption of signaling pathways that depend on
Notch-1, which is expressed in brain proliferative zones [15].
Here we describe a cortical dysplasia in PS1-deficient mice
which consists of leptomeningeal fibrosis and a multifocal
overmigration of cortical plate neurons beyond their
normal positions into the subarachnoid space — two key
features of human type 2 lissencephaly. The dysplasia
develops between embryonic day E13 and E18, well
before vascular lesions would become apparent in the neo-
cortical anlage. Neuronal overmigration is associated with
changes within the marginal zone, where both a reduced
number of Cajal–Retzius pioneer neurons and alternatives
in the extracellular matrix could be a cause of the dyspla-
sia. As in human type 2 lissencephaly, cortical malforma-
tion seems to be initiated by a defect in the
leptomeninges. Leptomeningeal fibroblasts show strong
immunoreactivity for PS1 before it appears in neurons, and
the leptomeninges exhibit a fibrotic change in both PS1-
knockout mice and human patients with lissencephaly.
Their functional impairment could negatively influence
the known trophic interaction of the leptomeningeal cells
with Cajal–Retzius neurons [23], thus initiating the disap-
pearance of the latter from the marginal zone.
Results
PS1-deficient mice exhibit midline defects and
malformations of the cerebral vascular system
We confirm the previously reported phenotypic changes
in PS1-deficient mice, including abnormal axial skeleton
formation [15,16]. As an hitherto unrecognized feature of
these mice, about one third (11 out of 30) developed
midline defects of the body wall and cranial vault. Specifi-
cally, we observed umbilical hernias containing loops of
small intestine, covered only by atrophic epithelium
(Figure 1a). In the skull, the posterior segment of the
sagittal suture immediately anterior to the occipital bone
had narrow clefts, through which brain and lep-
tomeningeal tissue protruded into the subcutaneous space
(Figure 1b). An apparently related disorder of the midline
region was observed in the same region, consisting of the
fusion of leptomeninges and adjacent brain tissue with the
inner surface of the cranial vault.
In addition to intracerebral hemorrhages [15], we found a
considerable reduction in the density of the cerebral vas-
culature in some brain regions. As early as E14, the
number of stainable vascular profiles was considerably
reduced within the basal hemispheres (Figure 1c,d) and
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Figure 1
PS1-deficient mice exhibit midline defects
and a regionally impaired cerebral
vasculogenesis. (a) In about 30% of the
homozygous PS1-deficient mice (–/–), the
abdominal wall exhibits herniations of various
sizes immediately adjacent to the umbilical
cord that are filled with several loops of small
intestine (Int) and are covered by thin dermis
and epithelium. UV, umbilical vein. The arrow
indicates margin of the bone anlage.
(b) Sagittal suture of a PS1-deficient embryo
at E14 in Goldner’s stain. The section is taken
rostral to lambda suture. Leptomeningeal
tissue protrudes from a region dorsal to the
diencephalic roof, passing through a narrow
cleft and forming a meningocele (Mce) within
the subcutaneous space. Arrows indicate
terminations of the bone anlagen. The third
ventricle can be seen at the bottom of the
photograph. (c–f) Comparison of normal
(+/+; c,e) and PSI-deficient (d,f) developing
brain. Within the cerebral anlage there was a
conspicuous reduction of the numbers of
small-caliber vessels in the basal hemispheres
(BH) as early as E14 (compare c and d). This
reduction in density persisted at least up to
E18 (compare e and f), the latest stage
investigated. Note that misconfigured larger
vessels (single arrows in (d,f) are preserved.
In between, capillaries are only rarely
encountered. Hemorrhages (double arrows in
(f)) become progressively prominent in these
regions during subsequent development.
Note that the lateral and dorsal cortical
anlagen (Cx) are not affected by this
malformation. Scale bars = 100 µm (a);
300 µm (b–d); 200 µm (e,f).
(a) (b)
(c) (d) (e) (f)
–/– –/–
+/+ –/–
+/+ –/–
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diencephalon (data not shown), whereas the vascular
architecture of the isocortical and allocortical fields
showed no detectable change. At E18, the latest stage
investigated here, the areas that showed early vascular
lesions are devastated by severe hemorrhages, whereas the
cortical fields still show no comparable abnormalities
(Figure 1e,f). This indicates that the pathomorphology
described below is not related to vascular lesions. 
PS1-deficient mice exhibit cortical dysplasia similar to
human type 2 lissencephaly
The cortical anlage of PS1-deficient E15 embryos consis-
tently exhibited numerous islands of ectopic neurons along
the brain surface (Figure 2a), as a result of overmigration of
cortical-plate neurons into the marginal zone and subarach-
noid space (Figure 2b,c). In these regions, the underlying
cortical plate was completely dissolved, indicating that
most if not all of the neurons of prospective laminae VI and
V had moved to these ectopic positions. Ectopic cortical
cell clusters were associated with a considerable fibrotic
thickening of leptomeninges, with up to five layers of
fibroblasts detected along the brain surface (Figure 2d,e;
Figure 3). In the neighborhood of  ectopic cortical cell clus-
ters, the meninges and their underlying basement mem-
brane either formed bulges ensheathing the overmigrated
neural tissue (Figure 2g) or showed gaps, through which
the neurons were directly exposed to the subarachnoid
space (Figure 2f–h). This finding is corroborated by stain-
ing with lectins from Solanum tuberosum (which binds to
vascular endothelia) and Ricinus communis (RCA-1, which
binds mesenchymal cells such as endothelia and fibrob-
lasts) as shown in Figure 2i–j. Ectopic neuronal tissue con-
tained only occasional small blood vessels, and therefore no
systematic relationship of the lesions to vascular entry
points at the brain surface could be established. Moreover,
the staining with RCA-1 allowed us to establish that the
neural cells, which do not stain with this lectin, remain as
solid aggregates and do not invade the fibrotic meninges.
These focal lesions were seen along the dorsal and lateral
aspects of the hemisphere wall, but did not occur in the
medial (the hippocampal) region. Related defects in the
normally clear delineation between the developing gray
matter and the marginal zone were observed along the
entire neuraxis, for example in brain stem and spinal cord,
but were not accompanied by protrusions into the sub-
arachnoid space (data not shown). At a later stage (E18),
subarachnoid ectopic cell clusters were less frequently
encountered, indicating that the ectopic cells might have
degenerated in their abnormal position. Lesioned areas of
the cortical plate could, however, still be identified by their
rugged appearance and the irregular thinning that indi-
cated a previous loss of neurons (Figure 4). 
PS1 is expressed early in leptomeningeal fibroblasts
In order to correlate the dysplastic cortical development
with the expression pattern of PS1, we monitored PS1
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Figure 2
Lissencephalic lesions in the cortical anlage of PS1-deficient mice.
(a) Hemisphere of a homozygous PS1-deficient (–/–) mouse at E15.
Along the circumference of the lateral and dorsal cortical anlage dorsal
to the rhinal fissure, protrusions of cortical-plate cell aggregates of
various sizes are seen within the marginal zone and/or within the
subarachnoid space (arrows). At this stage, the other laminae of the
cortical anlage appear intact. Similar ectopic aggregates are never
encountered in the medial cortical fields. The lateral ventricle (center of
photograph) is filled with erythrocytes. At higher magnification (b), it
becomes apparent that ectopic neurons completely disrupt the local
cortical plate (CP), the cells of which are shifted into the marginal zone
(MZ) and subarachnoid space (arrows). (c) A similar region from a wild-
type (+/+) littermate. Dashed lines indicate the position of the
leptomeninges. In PS1 knockout mice (d), the surface of the
hemisphere is covered by fibrotically thickened leptomeninges (dashed
lines) compared with wild-type mice (e). When viewed in the scanning
electron microscope, the meningeal cell layer (ME) is seen to be
continuous in wild-type mice (f) but appears ruptured in PS1-deficient
mice (g,h), and ectopic neurons (EN in (g)) are present as tightly
grouped neuronal cell clusters which are exposed to the subarachnoid
space. The observation that ectopic neurons remain clustered is further
exemplified by staining of leptomeningeal fibroblasts and endothelia with
the lectin RCA-1 (i), which shows that ectopic clusters are bracketed by
fibroblasts, but do not invade the leptomeningeal cell layer. Selective
staining of differentiating neurons with anti-neurofilament antibody
SMI-32 (j) also reveals ectopic cells grouped in clusters, but not, for
example, as single cells within meninges. Scale bars = 200 µm (a);
100 µm (b,c,i,j); 10 µm (d,e); 20 µm (f); 10 µm (g); 40 µm (h).
(a)
(b)
(c)
(d) (f)
(i)
(g)
(j)
(e) (h)
–/–
–/– –/–
–/–
–/––/–
+/+
+/+
–/–
+/+
Current Biology   
immunoreactivity during brain development. The first
cells in the developing brain to exhibit PS1 immunoreac-
tivity were leptomeningeal fibroblasts (Figure 3a). No
immunostaining was seen in PS1-deficient littermates,
which served as an additional control for the specificity of
antibody binding (Figure 3b). PS1 immunoreactivity was
unequally distributed in the meningeal cell layer, giving
intense staining signals around the lateral and basal
hemisphere surfaces and the diencephalon and brain
stem, but being almost undetectable over the medial
(hippocampal) hemisphere region (Figure 3c–f).
Further experiments with neonatal and juvenile wild-type
mice revealed a continuous decrease in meningeal
immunoreactivity after E18, resulting in a discontinuous
staining pattern from postnatal day 5 (P5) onward. Within
the cortical anlage, staining of neuronal cell bodies was
first seen between E18 and P0 and became prominent at
P5 (data not shown). No immunoreactivity for PS1 was
observed in Cajal–Retzius neurons during early develop-
ment (see marginal zone in Figure 3a).
To substantiate these findings, cultured meningeal cells
from wild-type mice explanted at P2 were analyzed by
immunocytochemistry and western blotting. Like the cells
in vivo, the cultured cells were strongly immunopositive for
PS1 using two independently generated antibodies —
11992 (Figure 3g; [24]) and B20.2 (W. Annaert,  unpub-
lished observations). In agreement with previous reports,
we observed a punctate staining pattern for PS1 (see the
insert in Figure 3g) compatible with its presence in intra-
cellular membrane compartments. Western blot analysis
confirmed the presence of PS1 in these cells (Figure 3h)
revealing a strongly immunopositive band migrating at the
same molecular weight as PS1 from fibroblasts, brain
homogenates and neuronal cultures (note that the neuronal
band comes from cells isolated from prenatal brain, but dif-
ferentiated in vitro for several days).
Development of ectopic cortical cell clusters is related to
changes in the marginal zone
The architectural development of the cortical plate is
known to depend on the presence of transient pioneer
neurons — the Cajal–Retzius cells — within the marginal
zone, and a specific organization of the local extracellular
matrix [25–28]. In particular, chondroitin sulfate proteo-
glycans (CSPGs) and the protein reelin/CR-50 antigen
have been proposed as ‘stop’ signals for neuronal migra-
tion [25,26]. To identify possible factors involved in the
generation of the observed ectopic neuronal clusters, we
have monitored both the development of Cajal–Retzius
neurons and the presence of CSPGs and reelin in the
extracellular matrix of the marginal zone.
In PS1-deficient mice the overall density of cells in the
marginal zone is considerably reduced during the period of
cortical development between E13 and E18 (Figure 4a–f;
see also Figure 5 for an intermediate stage), after being ini-
tally (E13) normal. Most notably, only a small number of
the ontogenetically crucial Cajal–Retzius cells can still be
seen at E18 (Figure 4g,h). The extracellular matrix of the
marginal zone is also considerably altered, with both CSPG
and reelin content being reduced (Figure 4i,j). The nor-
mally broad band of CSPG immunoreactivity within the
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Figure 3
Distribution of PS1 immunoreactivity in the cortical anlage. (a) In wild-
type embryos (+/+) at E14, PS1 immunoreactivity is present within
leptomeningeal fibroblasts (arrows) covering the basal and lateral
hemisphere surface. The neurons within the developing cortical plate
(CP) and also in the marginal zone (MZ) are still PS1 negative at this
stage. (b) As expected, meninges in PS1-deficient animals (–/–) are
PS1 negative (arrows).  (c–f) Meningeal PS1 expression shows
invariant regional differences along the brain surface in wild-type
animals. (c) Horizontal section of a left hemisphere (H) with adjacent
diencephalon (Di) of an E16 wild-type embryo. A representative field of
the isocortex (1) is enlarged in (d) and, at higher magnification, in (e),
and of the hippocampus (Hi; 2) in (f). Note the intense immunoreactivity
for PS1 (with antibody 11992) in isocortical meninges (Me) in (d,e),
where the arrow indicates a meningeal cell nucleus. Arrows indicate
the absence of PS1 immunoreactivity from the hippocampal surface in
(f) and its occurrence in meninges overlying the diencephalon (f).
(g) Cultured meningeal cells from early postnatal wild-type mice are
intensely immunoreactive for PS. The insert shows the granular staining
pattern. (h) Parallel subcultures from the same primary cultures were
analyzed by western blotting, and gave a single band at the expected
molecular weight of the amino-terminal PS1 fragment (Men, lane 1).
Similar fragments were detected in other tissues of wild type, but not of
PS1-deficient mice (lanes 2–7). Fibro, primary cultures of embryonic
fibroblasts; neurons, primary cultures of cortical neurons (E14); brain,
plasma-membrane-enriched material from brain (E14). Scale bars =
30 µm (a,b); 100 µm (c); 50 µm (d,f); 15 µm (e,g).
(a) (b) (c)
(d) (f)
(g)
(e)
(h)
+/+ +/+–/–
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marginal zone was reduced to a thin line, and regions of
missing or reduced immunoreactivity correlated with the
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Figure 4
Alterations of the marginal zone in PS1-knockout mice. The
appearance of the cortical anlage in wild-type (a–c) and PS1-
deficient (d–f) mice is shown in routine preparations at stages E13
(a,d), E16 (b,e) and E18 (c,f). The marginal zone is delimited by
dotted lines. Note that the initially similar number of cells in the
marginal zone at E13 (which should mostly be preplate neurons and
their superplate derivatives) becomes progressively reduced in
PS1-deficient mice. When the cortical analage is stained with
antibodies to calretinin as a specific marker for Cajal–Retzius neurons
at E18 (g,h), only a small number can be traced in PS1-deficient mice
(h) compared with the uninterrupted row in wild-type controls (g).
Reelin is also reduced in PS1-deficient mice (inserts in (g,h)).
Changes in the marginal zone cell population are exemplified by other
alterations in the local extracellular matrix. At E14, the marginal zone
exhibits intense immunoreactivity for CSPG (i), which is reduced to a
narrow band in PS1-deficient mice (j). Regions of subarachnoid
ectopic cells (asterisk in (j)) correlate with defects of the extracellular
matrix within the marginal zone (white arrowheads), where the
characteristic intense immunoreactivity for CSPG within the marginal
zone is interrupted. Scale bars = 20 µm (a,d); 50 µm (b,c,e,f); 30 µm
(g,h); 100 µm (i,j).
(a) (b) (c)
(d) (f)
(g) (h)
(i) (j)
(e)
+/+ +/+ +/+
–/– –/– –/–
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Figure 5
Differences in the expression of Notch-1 in the cortical anlage between
PS1-deficient and wild-type mice. (a) In wild-type mice the early
cortical anlage (E14) is characterized by expression of Notch-1 along
the cell membrane of large cells within the marginal zone (MZ, arrows)
and to a lesser degree on cortical-plate (CP) neuronal membranes.
(b) In PS1-knockouts, the Cajal–Retzius cell staining is reduced to
small patches in the marginal zone, and is completely absent from the
cortical plate. (c,d) Neurons in corresponding sections from wild-type
mice at E16 were stained with the neurofilament antibody SMI-32 (c)
or antibody to Notch-1 (d). The white arrows point towards horizontally
oriented neurons (Cajal–Retzius cells) in the marginal zone in (c).
Similar cells (arrowed) are stained by anti-Notch-1 in (d). (e) In E16
PS1-deficient embryos, the regular pattern of Notch-1
immunoreactivity is lost from the cortical anlage. Only very few
horizontal cells in the marginal zone (arrows) can still be stained for
this receptor protein. Double staining at E18 for calretinin and Notch-1
in wild-type (f,g) and PS1-deficient (h,i) mice again demonstrates a
clear localization of Notch-1 in Cajal–Retzius neurons (arrows pointing
to the same cells in (f,g)). In PS1-deficient mice, even the few
remaining pioneer neurons (marked by asterisks in (h)) are negative for
Notch-1 (i). Scale bars = 20 µm (a,b); 50 µm (c–e); 35 µm (f–i).
(a)
(b)
(c)
(d)
(f)
(i)
(g)
(e)
(h)
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–/– –/–
–/–
+/+ +/+
+/+
+/++/+
Current Biology   
occurrence of ectopic cortical cells (Figure 4a,b). It should
be noted that the differences in CSPG distribution devel-
oped only after E12. Interestingly, the cortical plate in PS1-
deficient mice at E18 shows an increased neuronal packing
density. As already noted [23], this defect likewise develops
after early postnatal selective degeneration of Cajal–Retzius
neurons following meningeal cell destruction.
Reduction and redistribution of Notch-1 immunoreactivity
in cortical anlage neurons of PS1-deficient mice
The association of PS1-related defects with alterations in
the Notch signaling pathway [16,17,20] prompted us to
investigate the expression pattern of Notch-1 in the cortical
anlage of PS1-deficient and wild-type mice. We have
observed a strong membrane-associated immunoreactivity
for Notch-1 in Cajal–Retzius neurons in wild-type mice,
starting with the onset of cortical-plate construction at E14
(Figure 5a,b). A less intense Notch-1 immunoreactivity,
which increased during development, was found in neurons
of the early cortical plate. At E16, Notch-1 immunostaining
was prominent in controls, in Cajal–Retzius cells in particu-
lar but also in cortical-plate neurons, whereas it was reduced
and redistributed in both cortical layers in PS1-deficient
mice (Figure 5c–e). At E18, controls still displayed a similar
pattern to that of E16, whereas double-labeling immunohis-
tochemistry of Cajal–Retzius neurons in PS1-deficient mice
revealed the complete absence of Notch-1 in the few
remaining cells (Figure 5f–i).
Discussion
PS1 deficiency leads to cortical dysplasia
Mice deficient in PS1 exhibit a characteristic pattern of
developmental malformations [16] consisting of a neuronal
migration disorder, midline defects of the body wall, a
region-specific destruction of blood vessels [15] and
defective somitogenesis. The key finding of our study is
the observation that PS1 deficiency is associated with a
characteristic developmental aberration in the cortical
anlage consisting of leptomeningeal fibrosis and neuronal
overmigration beyond the cortical plate, very similar to
human type 2 lissencephaly. In humans, this entity has
been found in a variety of inherited disorders such as
Walker–Warburg syndrome, Aicardi syndrome, Neu–Laxova
syndrome and Fukuyama syndrome [29–32]. As yet, the
positions of only some of the genes responsible for these
disorders have been mapped to different chromosomes
(none coinciding with the position of the human PS1
gene), indicating that type 2 lissencephaly might repre-
sent a final common pathway that can be triggered by dif-
ferent ‘upstream’ cellular alterations.
A common denominator in all these syndromes is the
primary involvement of the leptomeninges, which become
thickened by fibrosis, and defects of the basal lamina that
allow cortical neurons to trespass into the subarachnoid
space [33]. Consequently, neuronal overmigration has been
attributed to a hypothetical structural and/or functional
defect in a ‘meningoglial barrier’ at the brain surface [34],
consisting of pial fibroblasts, basal lamina and radial glia
endfeet, which is thought to participate in demarcating the
outer limit of neuronal movement. Also fitting into this
concept of a defective brain surface, distantly related phe-
notypes have been encountered in mice after experimental
destruction of genes encoding the integrin VLA6 [35] and
in human lissencephaly associated with defective merosin.
Pathogenesis of type 2 lissencephaly could be related to
defects in pioneer neurons
Mechanisms by which neurons from the distant ventricular
zone are attracted to the cortical plate and their migration
halted at the interface with the marginal zone have been
elucidated in considerably more detail in laboratory
animals. Both Cajal–Retzius neurons [36] and meningeal
cells [37–39] secrete chemotactic factors that attract migrat-
ing neurons to the surface of the cerebral anlage, whereas
the ‘stop’ signal probably resides in the extracellular matrix
of the marginal zone.  Notably, extracellular matrix synthe-
sis in this region appears to be predominantly a function of
Cajal–Retzius cells [27,40,41]. These pioneer neurons,
which control the establishment of cortical-plate architec-
ture, depend on trophic stimuli provided by the meninges
for their survival [23]. Evidence for the importance of mar-
ginal zone cells and extracellular matrix was originally pro-
vided by the reeler mutant mouse, in which the gene for
reelin, an extracellular matrix glycoprotein synthesized by
Cajal–Retzius neurons, was found to be defective [27,42].
This defect inhibits formation of a proper preplate and
causes a systemic abnormal positioning of cortical-plate
neurons [43,44]. Similar functions in the control of neu-
ronal migration in the central nervous system have been
proposed for CSPGs, but their apparent involvement
might be further modulated by region-specific association
with other matrix components (for a review see [26]). The
most direct evidence for the involvement of CSPGs is the
demonstration that their absence from the marginal zone in
MARCKS-deficient mice is associated with neuronal over-
migration [45,46]. CSPGs also direct migration of neuronal
crest cells and peripheral neurons [25].
The substantial loss of Cajal–Retzius neurons during the
development of PS1-deficient mice could thus explain the
observed loss from the marginal zone of CSPG and reelin,
which are normally involved in the termination of neu-
ronal migration. PS1 deficiency is, to our knowledge, the
first described defect in cortical development to be associ-
ated with a major loss of Cajal–Retzius cells from the corti-
cal anlage. Our findings point to a direct correlation
between the loss of these cells during development and
type 2 lissencephaly. The genesis of this cortical dysplasia
in humans is still poorly understood and has mostly been
related to as-yet-undefined brain surface lesions or genetic
defects of basal lamina constituents and their receptors
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[29–35]. Here we show that a deficiency in Cajal–Retzius
pioneer neurons, which hitherto have been studied mostly
in animal models, could lead to the same pathomorphol-
ogy, and that this might be caused by an underlying
meningeal cell defect. 
We tend to favor the suggestion that the net effect of
Cajal–Retzius cells on neuronal migration is inhibitory, as
already proposed [47], whereas the chemotactic function
can also be carried out by meningeal cells [37–39]. In
type 2 lissencephaly, meningeal cells become the ultimate
target of ectopic neurons. However, the cascade of events
leading to neuronal mispositioning requires further clarifi-
cation. For example, we need to know whether changes in
the secretion of proteases by migrating cells might con-
tribute to the marginal zone extracellular matrix defects,
as proposed in respect of CSPG [45,46]. Alternatively,
considering that morphologically related defects have also
been described as a consequence of defective VLA6 inte-
grins [35], PS1 might possibly have some effect on inte-
grin receptor function.
In PS1-deficient mice, the defects appear predominantly
to affect the early-migrating cells, with ectopic cell clus-
ters forming from E14 onward, whereas new ectopic clus-
ters do not appear to form around E18, indicating a more
stabilized architecture of the maturing cortical plate at that
late stage. Interestingly, the unusually tightly packed cor-
tical plate of PS1-deficient mice at that stage very much
resembles that of early postnatal mice in which the death
of Cajal–Retzius cells has been induced by selective
meningeal cell ablation [23], indicating a similar reaction
of late cortical ontogenesis to disabled pioneer neurons. 
Meningeal PS1 and Notch might have a crucial role in the
survival of Cajal–Retzius cells
Our hypothesis of the genesis of the observed ectopic cor-
tical cells accords well with current concepts of cortical
development, but the events linking PS1 deficiency to
the loss of Cajal–Retzius cells are less obvious. Our find-
ings show that PS1 is expressed early in leptomeningeal
fibroblasts, which have been shown to be essential for the
maintenance of the Cajal–Retzius cell population [23].
The fact that the leptomeningeal layer undergoes signifi-
cant fibrosis in PS1-deficient mice points to a primary role
for the PS1 deficiency in these cells in causing the cortical
dysplasia. This hypothesis is supported by the observa-
tion that PS1 is strongly expressed in the meninges that
cover the basal and lateral hemispheres, which show the
most extensive migration disorder, whereas it is virtually
absent from the meninges overlying the hippocampal
anlage, which is apparently not affected. Thus, one could
assume that PS1 deficiency in meningeal cells might
somehow interfere with their trophic action on
Cajal–Retzius neurons, leading to the loss of the latter
from the marginal zone. 
The reduction and redistribution of Notch-1 immunoreac-
tivity on Cajal–Retzius cell membranes could be the mor-
phological correlate of such a situation, caused either by
defective protein processing due to the absence of PS1 or
by a failure of Notch to interact properly with its ligands.
This assumption is supported by the recently demon-
strated participation of PS1 in the processing of APP and
secretion of β-amyloid peptide [13] as well as in the proteo-
lytic activation of Notch-1 [20,21]. A similar rearrangement
and reduction in Notch-1 is found on cortical-plate neurons
in PS1-deficient mice, which might also contribute to
defects of cortical-plate formation.
PS1-deficient mice have intracerebral hemorrhages that
are spatially related to a regional dysplasia of the microvas-
cular architecture. One could speculate that PS1-associ-
ated vascular disorders might be connected to the
hemorrhagic lesions that occur in the Alzheimer-related
CADASIL syndrome in humans, which is caused by
Notch-3 mutations [48,49]. In CADASIL (cerebral auto-
somal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy), hemorrhages have been attributed
to a degeneration of vascular smooth muscle cells which
may be triggered by pathologic changes in endothelial
permeability [50]. The recent demonstration that prese-
nilins are involved in the proteolytic activation of Notch
[20,21] could thus possibly explain the partial phenocopy
of Notch-3 defects caused by the absence of PS1.
Conclusions
As a consequence of its impact on γ-secretase function and
the proteolytic processing of the receptor protein Notch
[20–22,51], PS1 is involved in a multitude of developmen-
tal events [15,16]. Within the brain anlage, PS1 deficiency
interferes with the maintenance of the Cajal–Retzius
pioneer neuron population and (probably indirectly) with
the expression of Notch-1 on maturing neurons, eventu-
ally leading to cortical dysplasia related to human type 2
lissencephaly. As PS1 is expressed early in leptomeningeal
fibroblasts, which also exhibit pathologic changes of their
morphology in PS1-knockout mice, we propose that PS1
deficiency interferes with the essential trophic support
given to Cajal–Retzius cells by the leptomeninges, thus
triggering this cascade of abnormal development. 
Materials and methods
Animals
Generation of PS1-deficient mice has already been described [13].
The mice were kept in a conventional animal facility. Animals were
mated overnight and conception was determined by the detection of
vaginal plugs. The morning following mating was counted as embryonic
day (E) 0.5. Genotyping was performed using tissue removed from the
embryos before fixation [13].
Fixation and embedding
Pregnant animals were killed by an overdose of narcotics and the
embryos removed by cesarian section. Fetuses up to E15 were fixed
by immersion in Bouin’s solution diluted 1:3 by PBS; older animals
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were fixed by transcardiac perfusion with the same fixative. For routine
histology and immunohistochemistry, material was either frozen in
liquid nitrogen and sectioned on a cryomicrotome or embedded in
paraffin wax. Serial sections 7 µm thick were dewaxed in xylene and
stained with hematoxylin and eosin or Goldner’s stain according to
routine procedures.
Immunohistochemistry and lectin histochemistry
Endothelial cells were detected by the use of biotinylated lectin from
Solanum tuberosum (Vector, Burlingame, USA). Biotinylated Ricinus
communis lectin (RCA-1; also from Vector) was used to stain endothe-
lia and other cells of mesenchymal origin, such as fibroblasts or acti-
vated microglia/macrophages. For the visualization of PS1, antibodies
11992 (kindly provided by N. Robakis) [24] and B19.2 (kindly provided
by W. Annaert) were used. Antibodies to reelin (clone G10; [52]) were
a gift from A. M. Goffinet, Namur, Belgium. For the detection of CSPG,
a commercially available monoclonal antibody (clone CS56; Sigma)
that binds to the glycosaminoglycan portion of CSPG types A and C,
but not B, were used for the photomicrographs shown in this paper.
Additional analyses were made with antibodies to phosphacan (clone
6B4, kindly donated by N. Maeda; [41]). Polyclonal antisera to calre-
tinin and Notch-1 were obtained from Chemicon, Temecula, USA and
from Santa Cruz, USA, respectively. Neurons were stained with anti-
bodies SMI-31 and SMI-32, which bind to phosphorylated and non-
phosphorylated neurofilaments, respectively (Sternberger Monoclonals,
USA). Detection of primary reagents (except for already biotin-tagged
lectins) was performed using biotinylated secondary andibodies fol-
lowed by either fluorochrome-labeled avidin or avidin coupled to horse-
radish peroxidase. The latter was then visualized by tyramide signal
amplification (NEN-Dupont).
Scanning electron microscopy 
E14 and E18 fetuses were fixed by transcardiac perfusion with 6% glu-
taraldehyde in phosphate buffer. Cerebral hemispheres were then
postfixed for 2 h in a solution of 2% OsO4 containg 6.5% sucrose and
dehydrated in a graded series of ethanol, which was then exchanged
for acetone. This intermediate was removed in a critical point dryer
(Balzer, FRG) at 40 atm. After covering with gold (sputter equipment
from IonTech, UK), specimens were photographed in a Philips XL25
scanning electron microscope.
Western blotting of meningeal cell cultures
Meningeal cell cultures were prepared as described [34,35]. Cells
from the first subculture passage were seeded on glass coverslips for
direct immunohistochemical analysis or propagated in plastic flasks
until confluency for western blotting. After harvesting, pellets were solu-
bilized in SDS sample buffer. Protein (50 µg) was applied to each lane
and fractionated on a 4–20% Tris-glycine gel. The material was trans-
fered to a nitrocellulose sheet and reacted with antibody B19.2
(1:25.000), which is specific for the amino terminus of PS1, and goat
anti-rabbit antibodies conjugated to horseradish peroxidase (1:5000).
The blot was developed using an ECL kit (Amersham, UK) according to
the manufacturer’s instructions.
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